Company / Cash per Share
Structure Therapeutics Inc. Cash per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.50
FY2025
5-year range
$1.07 / $4.50
FY2022-FY2025
Trend
+319.5%
vs FY2024
Sector context
#47 of 205
Health Care
What the data says
Cash per Share changed +319% YoY in FY2025, a notable deviation from the 3-year average annual change of +85%.
Based on SEC 10-K filings.
4.50 in FY2025 with a 3-year CAGR of +18.3%. Top quartile in the Health Care sector.
Improved from $1.18 to $4.50 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +18.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 205This company $4.50 Sector average $72.93
▼
-93.8% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 319.5% year-over-year.
- Ranks #47 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 9.77 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.50 | +319.5% |
| FY2024 | $1.07 | -8.9% |
| FY2023 | $1.18 | -56.7% |
| FY2022 | $2.72 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026